Saturday, December 03, 2005

Another Portfolio Update

Well another month has gone by and the years almost over. How time flies, huh? Here's my current non retirement portfolio with the % holding and % return for each holding. The only thing I really need to do is to sell Pfizer before year end to realize the loss. This one really bugged me. I had a nice gain in Pfizer and has now developed into a loss. This should never have happened! I'll learn from this mistake.

Ticker % of Portfolio% Return
Amgen (AMGN) 2.88% +4.48%
Biogen Idec (BIIB) 3.09% -22.48%
Boston Scientific (BSX) 3.89% -4.61%
Cytyc (CYTC) 0.99% -1.17%
Genzyme (GENZ) 63.97% +287.72%
Invitrogen (IVGN) 3.64% +312.68%
Microsoft (MSFT) 1.13% -29.09%
NASDAQ 100 (QQQQ) 1.50% +51.71%
Qiagen (QGEN) 10.19% +208.88%
Pfizer (PFE) 4.10% -25.30%
Sepracor (SEPR) 0.99% -9.02%
Cash 3.59%

I usually don't trade much in order to minimize taxes and transaction costs. Here are all of the trades I executed this year with the % return. The only one I regretted selling was Apple; that was a bad trade. I sold Apple way too soon :( I'm not going to complain. It's been a very good year and I'll be writing a big check to Uncle Sam this tax year.

Ticker % Return
Apple (AAPL) +10.39%
Fisher Scientific (FSH) +20.96%
Genzyme (GENZ) +243.75%
Johnson & Johnson (JNJ) +8.69%
Las Vegas Sands (LVS) +20.79%


At December 05, 2005, Blogger Mathieu said...

Pretty impressive record in the field of drugs and biotech.

No technical charts, FCF valuation or whatever can beat real knowledge of an industry I guess.

Congrats on the performance
(I was happy with my +15% in 6 months, but you blew me away)

At December 05, 2005, Blogger Money Turtle said...

These were total returns (not annualized). I'll crunch some numbers and post the annualized returns.

At December 05, 2005, Blogger Dwight said...

Boston Scientific sure threw a wrench into the Guidant buy-out today. This will be interesting to see how it plays out.

At December 06, 2005, Blogger Money Turtle said...

I play it safe with my retirement portfolio. The majority (~83%) of my retirement account is invested in mutual funds and only 17% is invested in individual stocks. I don't mess around with my retirement stuff...

At December 14, 2005, Anonymous Anonymous said...

I see you are lacking in Bristol-Myers Squibb (BMY). Have you taken a look at them. Personally I feel they are undervalued as they both pay a high dividend (and have indicated that they will continue to do so) and a relatively strong drug pipeline. I like the company a lot and feel that it has been neglected by investors. Take a look and let me know what you think.

Full disclosure: I own several hundred shares of BMY as well as several Jan 2008 25.00 Call options.

At December 16, 2005, Blogger Money Turtle said...

I have followed BMY off and on. I would agree that it's a good value play. No one likes them right now, which is a good time to buy. I already have a sizable position in PFE, but I may sell PFE for a tax loss and switch the funds to another pharma company. We'll see...


Post a Comment

<< Home